DexCom EBITDA 2010-2024 | DXCM
DexCom annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- DexCom EBITDA for the quarter ending September 30, 2024 was $0.207B, a 18.29% decline year-over-year.
- DexCom EBITDA for the twelve months ending September 30, 2024 was $0.840B, a 24.32% increase year-over-year.
- DexCom 2023 annual EBITDA was $0.784B, a 43.25% increase from 2022.
- DexCom 2022 annual EBITDA was $0.547B, a 48.75% increase from 2021.
- DexCom 2021 annual EBITDA was $0.368B, a 0.33% increase from 2020.
| DexCom Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $784 |
| 2022 | $547 |
| 2021 | $368 |
| 2020 | $367 |
| 2019 | $191 |
| 2018 | $-157 |
| 2017 | $-26 |
| 2016 | $-49 |
| 2015 | $-46 |
| 2014 | $-13 |
| 2013 | $-21 |
| 2012 | $-48 |
| 2011 | $-40 |
| 2010 | $-42 |
| 2009 | $-42 |
| DexCom Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-09-30 | $207 |
| 2024-06-30 | $210 |
| 2024-03-31 | $154 |
| 2023-12-31 | $269 |
| 2023-09-30 | $254 |
| 2023-06-30 | $172 |
| 2023-03-31 | $89 |
| 2022-12-31 | $162 |
| 2022-09-30 | $187 |
| 2022-06-30 | $121 |
| 2022-03-31 | $78 |
| 2021-12-31 | $33 |
| 2021-09-30 | $144 |
| 2021-06-30 | $125 |
| 2021-03-31 | $67 |
| 2020-12-31 | $124 |
| 2020-09-30 | $113 |
| 2020-06-30 | $83 |
| 2020-03-31 | $47 |
| 2019-12-31 | $116 |
| 2019-09-30 | $69 |
| 2019-06-30 | $11 |
| 2019-03-31 | $-5 |
| 2018-12-31 | $-156 |
| 2018-09-30 | $22 |
| 2018-06-30 | $2 |
| 2018-03-31 | $-25 |
| 2017-12-31 | $16 |
| 2017-09-30 | $4 |
| 2017-06-30 | $-10 |
| 2017-03-31 | $-37 |
| 2016-12-31 | $-3 |
| 2016-09-30 | $-14 |
| 2016-06-30 | $-16 |
| 2016-03-31 | $-16 |
| 2015-12-31 | $4 |
| 2015-09-30 | $-40 |
| 2015-06-30 | $-1 |
| 2015-03-31 | $-10 |
| 2014-12-31 | $4 |
| 2014-09-30 | $-3 |
| 2014-06-30 | $-4 |
| 2014-03-31 | $-10 |
| 2013-12-31 | $-0 |
| 2013-09-30 | $-4 |
| 2013-06-30 | $-8 |
| 2013-03-31 | $-9 |
| 2012-12-31 | $-6 |
| 2012-09-30 | $-15 |
| 2012-06-30 | $-13 |
| 2012-03-31 | $-14 |
| 2011-12-31 | $-11 |
| 2011-09-30 | $-12 |
| 2011-06-30 | $-6 |
| 2011-03-31 | $-11 |
| 2010-12-31 | $-9 |
| 2010-09-30 | $-12 |
| 2010-06-30 | $-10 |
| 2010-03-31 | $-10 |
| 2009-12-31 | $-9 |
| 2009-09-30 | $-11 |
| 2009-06-30 | $-12 |
| 2009-03-31 | $-10 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $30.627B | $3.622B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $205.491B | 25.07 |
| Intuitive Surgical (ISRG) | United States | $191.931B | 100.35 |
| Alcon (ALC) | Switzerland | $42.651B | 28.54 |
| Edwards Lifesciences (EW) | United States | $41.817B | 26.55 |
| IQVIA Holdings (IQV) | United States | $37.469B | 20.64 |
| IDEXX Laboratories (IDXX) | United States | $36.904B | 43.46 |
| Waters (WAT) | United States | $23.276B | 34.42 |
| STERIS (STE) | Ireland | $21.284B | 24.50 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.097B | 0.00 |
| Hologic (HOLX) | United States | $17.200B | 18.58 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.078B | 14.45 |
| Sysmex ADR (SSMXY) | Japan | $13.104B | 41.09 |
| Globus Medical (GMED) | United States | $11.291B | 28.59 |
| Penumbra (PEN) | United States | $9.244B | 90.55 |
| Masimo (MASI) | United States | $9.076B | 43.92 |
| Teleflex (TFX) | United States | $8.687B | 13.85 |
| Glaukos (GKOS) | United States | $7.647B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.828B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.639B | 26.30 |
| Veracyte (VCYT) | United States | $3.314B | 99.44 |
| Inari Medical (NARI) | United States | $3.126B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.714B | 15.67 |
| Nihon Kohden (NHNKY) | Japan | $2.347B | 17.83 |
| TransMedics (TMDX) | United States | $2.344B | 74.30 |
| Elekta AB (EKTAY) | Sweden | $2.216B | 19.92 |
| Tandem Diabetes Care (TNDM) | United States | $2.108B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.881B | 9.83 |
| RxSight (RXST) | United States | $1.599B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.363B | 0.00 |
| Artivion (AORT) | United States | $1.216B | 80.56 |
| Pulse Biosciences (PLSE) | United States | $1.152B | 0.00 |
| OPKO Health (OPK) | United States | $1.078B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.852B | 14.48 |
| Paragon 28 (FNA) | United States | $0.837B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.712B | 16.78 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.699B | 0.00 |
| IRadimed (IRMD) | United States | $0.693B | 37.47 |
| AxoGen (AXGN) | United States | $0.646B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.597B | 0.00 |
| SiBone (SIBN) | United States | $0.570B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.544B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.515B | 30.30 |
| Treace Medical Concepts (TMCI) | United States | $0.493B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.441B | 23.84 |
| ClearPoint Neuro (CLPT) | United States | $0.404B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.370B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.351B | 0.00 |
| CVRx (CVRX) | United States | $0.331B | 0.00 |
| NeuroPace (NPCE) | United States | $0.327B | 0.00 |
| Inogen (INGN) | United States | $0.227B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.215B | 0.00 |
| Accuray (ARAY) | United States | $0.210B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.187B | 0.00 |
| Nevro (NVRO) | United States | $0.163B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.157B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.143B | 15.26 |
| Spectral Diagnostics (EDTXF) | Canada | $0.105B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.094B | 0.00 |
| LENSAR (LNSR) | United States | $0.090B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.089B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.084B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.084B | 0.00 |
| 908 Devices (MASS) | United States | $0.083B | 0.00 |
| InspireMD (NSPR) | Israel | $0.082B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.071B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.053B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.048B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.045B | 0.00 |
| Envoy Medical (COCH) | United States | $0.044B | 0.00 |
| Spectral AI (MDAI) | United States | $0.038B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.038B | 0.00 |
| Neuronetics (STIM) | United States | $0.035B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| NexGel (NXGL) | United States | $0.025B | 0.00 |
| DarioHealth (DRIO) | United States | $0.023B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.019B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.015B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.012B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.012B | 0.00 | |
| T2 Biosystems (TTOO) | United States | $0.011B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |